This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Practice Guideline

. 2014 Sep:25 Suppl 3:iii1-9.

doi: 10.1093/annonc/mdu260. Epub 2014 Sep 4.

Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

E Van Cutsem¹, A Cervantes², B Nordlinger³, D Arnold⁴; ESMO Guidelines Working Group

Collaborators, Affiliations

Collaborators

Affiliations

¹ Digestive Oncology, University Hospitals Leuven, Leuven, Belgium.
² Department of Hematology and Medical Oncology, INCLIVA, University of Valencia, Valencia, Spain.
³ Department of General Surgery and Surgical Oncology, Hôpital Ambroise Paré, Assistance Publique - Hôpitaux de Paris, Paris, France.
⁴ Klinik für Tumorbiologie, Freiburg, Germany.

PMID: 25190710
DOI: 10.1093/annonc/mdu260

Free article

Practice Guideline

Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

E Van Cutsem et al. Ann Oncol. 2014 Sep.

Free article

. 2014 Sep:25 Suppl 3:iii1-9.

doi: 10.1093/annonc/mdu260. Epub 2014 Sep 4.

Authors

E Van Cutsem¹, A Cervantes², B Nordlinger³, D Arnold⁴; ESMO Guidelines Working Group

Collaborators

Affiliations

¹ Digestive Oncology, University Hospitals Leuven, Leuven, Belgium.
² Department of Hematology and Medical Oncology, INCLIVA, University of Valencia, Valencia, Spain.
³ Department of General Surgery and Surgical Oncology, Hôpital Ambroise Paré, Assistance Publique - Hôpitaux de Paris, Paris, France.
⁴ Klinik für Tumorbiologie, Freiburg, Germany.

PMID: 25190710
DOI: 10.1093/annonc/mdu260

Erratum in

The ESMO Guidelines Committee would like to publish the following corrections to manuscripts published in 2014.
[No authors listed] [No authors listed] Ann Oncol. 2015 Sep;26 Suppl 5:v174-7. doi: 10.1093/annonc/mdv204. Epub 2015 Jul 21. Ann Oncol. 2015. PMID: 26199393 No abstract available.

No abstract available

PubMed Disclaimer

Similar articles

Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Reck M, Popat S, Reinmuth N, De Ruysscher D, Kerr KM, Peters S; ESMO Guidelines Working Group. Reck M, et al. Ann Oncol. 2014 Sep;25 Suppl 3:iii27-39. doi: 10.1093/annonc/mdu199. Epub 2014 Aug 11. Ann Oncol. 2014. PMID: 25115305 No abstract available.
Advanced colorectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Van Cutsem E, Oliveira J; ESMO Guidelines Working Group. Van Cutsem E, et al. Ann Oncol. 2009 May;20 Suppl 4:61-3. doi: 10.1093/annonc/mdp130. Ann Oncol. 2009. PMID: 19454465 Review. No abstract available.
Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up.
Bellmunt J, Orsola A, Leow JJ, Wiegel T, De Santis M, Horwich A; ESMO Guidelines Working Group. Bellmunt J, et al. Ann Oncol. 2014 Sep;25 Suppl 3:iii40-8. doi: 10.1093/annonc/mdu223. Epub 2014 Aug 5. Ann Oncol. 2014. PMID: 25096609 No abstract available.
Anal cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Glynne-Jones R, Nilsson PJ, Aschele C, Goh V, Peiffert D, Cervantes A, Arnold D. Glynne-Jones R, et al. Ann Oncol. 2014 Sep;25 Suppl 3:iii10-20. doi: 10.1093/annonc/mdu159. Epub 2014 Jul 6. Ann Oncol. 2014. PMID: 25001200 No abstract available.
Familial colorectal cancer risk: ESMO clinical recommendations.
Vasen HF, van der Meulen-de Jong AE, de Vos Tot Nederveen Cappel WH, Oliveira J; ESMO Guidelines Working Group. Vasen HF, et al. Ann Oncol. 2009 May;20 Suppl 4:51-3. doi: 10.1093/annonc/mdp127. Ann Oncol. 2009. PMID: 19454462 Review. No abstract available.

See all similar articles

Cited by

RANK promotes colorectal cancer migration and invasion by activating the Ca²⁺-calcineurin/NFATC1-ACP5 axis.
Liang Q, Wang Y, Lu Y, Zhu Q, Xie W, Tang N, Huang L, An T, Zhang D, Yan A, Liu S, Ye L, Zhu C. Liang Q, et al. Cell Death Dis. 2021 Apr 1;12(4):336. doi: 10.1038/s41419-021-03642-7. Cell Death Dis. 2021. PMID: 33795653 Free PMC article.
Ramucirumab in metastatic colorectal cancer: evidence to date and place in therapy.
Verdaguer H, Tabernero J, Macarulla T. Verdaguer H, et al. Ther Adv Med Oncol. 2016 May;8(3):230-42. doi: 10.1177/1758834016635888. Epub 2016 Mar 11. Ther Adv Med Oncol. 2016. PMID: 27239240 Free PMC article. Review.
Towards precision medicine in colorectal cancer liver metastases.
O'Connor JM, Loria FS. O'Connor JM, et al. Hepat Oncol. 2020 Jul 29;7(3):HEP29. doi: 10.2217/hep-2020-0011. Hepat Oncol. 2020. PMID: 32774838 Free PMC article. No abstract available.
Mutational analysis of primary and metastatic colorectal cancer samples underlying the resistance to cetuximab-based therapy.
Nemecek R, Berkovcova J, Radova L, Kazda T, Mlcochova J, Vychytilova-Faltejskova P, Slaby O, Svoboda M. Nemecek R, et al. Onco Targets Ther. 2016 Jul 28;9:4695-703. doi: 10.2147/OTT.S102891. eCollection 2016. Onco Targets Ther. 2016. PMID: 27555788 Free PMC article.
DKK1 as a chemoresistant protein modulates oxaliplatin responses in colorectal cancer.
Hsieh CC, Li TW, Li CC, Chen SH, Wei YL, Chiang NJ, Shen CH. Hsieh CC, et al. Oncogenesis. 2024 Sep 27;13(1):34. doi: 10.1038/s41389-024-00537-y. Oncogenesis. 2024. PMID: 39333078 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Medical
- MedlinePlus Health Information